Health care leaders’ letter to the FDA: Concerns about approvals for rare disease therapeuticsNovember 21, 2025
Market Selloff on Renewed AI Bubble Fears; Lagarde Urges EU Reform | The Pulse 11/21November 21, 2025
Health care leaders’ letter to the FDA: Concerns about approvals for rare disease therapeuticsNovember 21, 2025
Market Selloff on Renewed AI Bubble Fears; Lagarde Urges EU Reform | The Pulse 11/21November 21, 2025
Share Facebook Twitter LinkedIn Pinterest Email Sheila Kahyaoglu, Jefferies defense analyst, joins CNBC’s ‘The Exchange’ to discuss the impact of Iran’s missile strikes on defense stocks, U.S. defense spending, and more.